-
1
-
-
0028135393
-
Renal function in newly diagnosed multiple myeloma-a demographic study of 1353 patients
-
The Nordic Myeloma Study Group, 1994
-
Knudsen L.M., Hippe E., Hjorth M., et al. Renal function in newly diagnosed multiple myeloma-a demographic study of 1353 patients. Eur J Haematol 1994, 53:207-212. The Nordic Myeloma Study Group, 1994.
-
(1994)
Eur J Haematol
, vol.53
, pp. 207-212
-
-
Knudsen, L.M.1
Hippe, E.2
Hjorth, M.3
-
2
-
-
0033851432
-
Renal failure in multiple myeloma: reversibility and impact on the prognosis
-
Nordic Myeloma Study Group
-
Knudsen L.M., Hjorth M., Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Eur J Haematol 2000, 65:175-181. Nordic Myeloma Study Group.
-
(2000)
Eur J Haematol
, vol.65
, pp. 175-181
-
-
Knudsen, L.M.1
Hjorth, M.2
Hippe, E.3
-
3
-
-
0032575885
-
Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution
-
Blade J., Fernandez-Llama P., Bosch F., et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 1998, 158:1889-1893.
-
(1998)
Arch Intern Med
, vol.158
, pp. 1889-1893
-
-
Blade, J.1
Fernandez-Llama, P.2
Bosch, F.3
-
4
-
-
79951891171
-
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group
-
Dimopoulos M.A., Terpos E., Chanan-Khan A., et al. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 2010, 28:4976-4984.
-
(2010)
J Clin Oncol
, vol.28
, pp. 4976-4984
-
-
Dimopoulos, M.A.1
Terpos, E.2
Chanan-Khan, A.3
-
5
-
-
33748692003
-
Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK Multiple Myeloma Trials
-
Drayson M., Begum G., Basu S., et al. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK Multiple Myeloma Trials. Blood 2006, 108:2013-2019.
-
(2006)
Blood
, vol.108
, pp. 2013-2019
-
-
Drayson, M.1
Begum, G.2
Basu, S.3
-
6
-
-
84455205655
-
The pathogenesis and diagnosis of acute kidney injury in multiple myeloma
-
Hutchison C.A., Batuman V., Behrens J., et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol 2012, 8:43-51.
-
(2012)
Nat Rev Nephrol
, vol.8
, pp. 43-51
-
-
Hutchison, C.A.1
Batuman, V.2
Behrens, J.3
-
7
-
-
0025020662
-
Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins
-
Sanders P.W., Booker B.B., Bishop J.B., et al. Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest 1990, 85:570-576.
-
(1990)
J Clin Invest
, vol.85
, pp. 570-576
-
-
Sanders, P.W.1
Booker, B.B.2
Bishop, J.B.3
-
8
-
-
0026607225
-
Pathobiology of cast nephropathy from human Bence Jones proteins
-
Sanders P.W., Booker B.B. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 1992, 89:630-639.
-
(1992)
J Clin Invest
, vol.89
, pp. 630-639
-
-
Sanders, P.W.1
Booker, B.B.2
-
9
-
-
77951686835
-
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus
-
Cairo M.S., Coiffier B., Reiter A., et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010, 149:578-586.
-
(2010)
Br J Haematol
, vol.149
, pp. 578-586
-
-
Cairo, M.S.1
Coiffier, B.2
Reiter, A.3
-
10
-
-
43749109850
-
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains
-
Leung N., Gertz M.A., Zeldenrust S.R., et al. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int 2008, 73:1282-1288.
-
(2008)
Kidney Int
, vol.73
, pp. 1282-1288
-
-
Leung, N.1
Gertz, M.A.2
Zeldenrust, S.R.3
-
11
-
-
66449132961
-
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis
-
Hutchison C.A., Bradwell A.R., Cook M., et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 2009, 4:745-754.
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 745-754
-
-
Hutchison, C.A.1
Bradwell, A.R.2
Cook, M.3
-
12
-
-
79958846304
-
Guidelines for the diagnosis and management of multiple myeloma 2011
-
Bird J.M., Owen R.G., D'Sa S., et al. Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol 2011, 154:32-75.
-
(2011)
Br J Haematol
, vol.154
, pp. 32-75
-
-
Bird, J.M.1
Owen, R.G.2
D'Sa, S.3
-
13
-
-
84857444683
-
Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress [in French]
-
Bridoux F., Delbes S., Sirac C., et al. Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress [in French]. Presse Med 2012, 41:276-289.
-
(2012)
Presse Med
, vol.41
, pp. 276-289
-
-
Bridoux, F.1
Delbes, S.2
Sirac, C.3
-
14
-
-
0025269491
-
Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy
-
Johnson W.J., Kyle R.A., Pineda A.A., et al. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 1990, 150:863-869.
-
(1990)
Arch Intern Med
, vol.150
, pp. 863-869
-
-
Johnson, W.J.1
Kyle, R.A.2
Pineda, A.A.3
-
15
-
-
54949089153
-
Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients
-
Soares S.M., Fervenza F.C., Lager D.J., et al. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients. Am J Kidney Dis 2008, 52:1079-1083.
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 1079-1083
-
-
Soares, S.M.1
Fervenza, F.C.2
Lager, D.J.3
-
16
-
-
78049308138
-
The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies
-
Fish R., Pinney J., Jain P., et al. The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies. Clin J Am Soc Nephrol 2010, 5:1977-1980.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 1977-1980
-
-
Fish, R.1
Pinney, J.2
Jain, P.3
-
17
-
-
0024994777
-
Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma
-
Ivanyi B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990, 114:986-987.
-
(1990)
Arch Pathol Lab Med
, vol.114
, pp. 986-987
-
-
Ivanyi, B.1
-
18
-
-
79957706775
-
Early reduction of serum-free light chains associates with renal recovery in myeloma kidney
-
Hutchison C.A., Cockwell P., Stringer S., et al. Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol 2011, 22:1129-1136.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 1129-1136
-
-
Hutchison, C.A.1
Cockwell, P.2
Stringer, S.3
-
19
-
-
77950233020
-
Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease
-
Lorenz E.C., Sethi S., Poshusta T.L., et al. Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease. Nephrol Dial Transplant 2010, 25:1340-1343.
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 1340-1343
-
-
Lorenz, E.C.1
Sethi, S.2
Poshusta, T.L.3
-
20
-
-
0034911594
-
Renal monoclonal immunoglobulin deposition disease: the disease spectrum
-
Lin J., Markowitz G.S., Valeri A.M., et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 2001, 12:1482-1492.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1482-1492
-
-
Lin, J.1
Markowitz, G.S.2
Valeri, A.M.3
-
21
-
-
0035007762
-
Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate
-
Markowitz G.S., Appel G.B., Fine P.L., et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 2001, 12:1164-1172.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1164-1172
-
-
Markowitz, G.S.1
Appel, G.B.2
Fine, P.L.3
-
22
-
-
0036439015
-
Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma
-
Desikan R., Veksler Y., Raza S., et al. Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. Br J Haematol 2002, 119:496-499.
-
(2002)
Br J Haematol
, vol.119
, pp. 496-499
-
-
Desikan, R.1
Veksler, Y.2
Raza, S.3
-
23
-
-
84965004802
-
MRC working party on leukaemia in adults
-
Analysis and management of renal failure in fourth MRC myelomatosis trial
-
MRC working party on leukaemia in adults. Br Med J 1984, 288:1411-1416. Analysis and management of renal failure in fourth MRC myelomatosis trial.
-
(1984)
Br Med J
, vol.288
, pp. 1411-1416
-
-
-
24
-
-
0031444110
-
Presentation and survival of patients with severe renal failure and myeloma
-
Irish A.B., Winearls C.G., Littlewood T. Presentation and survival of patients with severe renal failure and myeloma. Q J Med 1997, 90:773-780.
-
(1997)
Q J Med
, vol.90
, pp. 773-780
-
-
Irish, A.B.1
Winearls, C.G.2
Littlewood, T.3
-
25
-
-
0027942872
-
Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases
-
Blade J., Lust J.A., Kyle R.A. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 1994, 12:2398-2404.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2398-2404
-
-
Blade, J.1
Lust, J.A.2
Kyle, R.A.3
-
26
-
-
84860580187
-
Treating myeloma cast nephropathy without treating myeloma
-
Leung N. Treating myeloma cast nephropathy without treating myeloma. J Clin Invest 2012, 122:1605-1608.
-
(2012)
J Clin Invest
, vol.122
, pp. 1605-1608
-
-
Leung, N.1
-
27
-
-
0017579659
-
Multiple myeloma with massive Bence Jones proteinuria and preservation of renal function
-
Woodruff R., Sweet B. Multiple myeloma with massive Bence Jones proteinuria and preservation of renal function. Aust N Z J Med 1977, 7:60-62.
-
(1977)
Aust N Z J Med
, vol.7
, pp. 60-62
-
-
Woodruff, R.1
Sweet, B.2
-
28
-
-
84860553777
-
Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent model
-
Ying W.Z., Allen C.E., Curtis L.M., et al. Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent model. J Clin Invest 2012, 122:1777-1785.
-
(2012)
J Clin Invest
, vol.122
, pp. 1777-1785
-
-
Ying, W.Z.1
Allen, C.E.2
Curtis, L.M.3
-
29
-
-
53649091574
-
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
-
Hutchison C.A., Plant T., Drayson M., et al. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol 2008, 9:11.
-
(2008)
BMC Nephrol
, vol.9
, pp. 11
-
-
Hutchison, C.A.1
Plant, T.2
Drayson, M.3
-
30
-
-
79958826321
-
Serum FLC levels can be reduced rapidly; lower levels are associated with renal recovery
-
Drayson M.T., Behrens J., Cohen D.R., et al. Serum FLC levels can be reduced rapidly; lower levels are associated with renal recovery. Clin Lymphoma Myeloma 2009, 9:S57-S58.
-
(2009)
Clin Lymphoma Myeloma
, vol.9
-
-
Drayson, M.T.1
Behrens, J.2
Cohen, D.R.3
-
31
-
-
0038007193
-
Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia
-
Harris E., Behrens J., Samson D., et al. Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia. Br J Haematol 2003, 122:160-161.
-
(2003)
Br J Haematol
, vol.122
, pp. 160-161
-
-
Harris, E.1
Behrens, J.2
Samson, D.3
-
32
-
-
84862937267
-
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis
-
Morgan G.J., Gregory W.M., Davies F.E., et al. The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis. Blood 2012, 119:7-15.
-
(2012)
Blood
, vol.119
, pp. 7-15
-
-
Morgan, G.J.1
Gregory, W.M.2
Davies, F.E.3
-
33
-
-
78049507882
-
Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study
-
Ludwig H., Adam Z., Hajek R., et al. Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study. J Clin Oncol 2010, 28:4635-4641.
-
(2010)
J Clin Oncol
, vol.28
, pp. 4635-4641
-
-
Ludwig, H.1
Adam, Z.2
Hajek, R.3
-
34
-
-
77953862198
-
The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function
-
Dimopoulos M., Alegre A., Stadtmauer E.A., et al. The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function. Cancer 2010, 116:3807-3814.
-
(2010)
Cancer
, vol.116
, pp. 3807-3814
-
-
Dimopoulos, M.1
Alegre, A.2
Stadtmauer, E.A.3
-
35
-
-
79952126085
-
Kidney dysfunction during lenalidomide treatment for AL amyloidosis
-
Specter R., Sanchorawala V., Seldin D.C., et al. Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Nephrol Dial Transplant 2011, 26:881-886.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 881-886
-
-
Specter, R.1
Sanchorawala, V.2
Seldin, D.C.3
-
36
-
-
0017235212
-
Successful treatment of myeloma kidney by diuresis and plasmapheresis
-
Feest T.G., Burge P.S., Cohen S.L. Successful treatment of myeloma kidney by diuresis and plasmapheresis. Br Med J 1976, 1:503-504.
-
(1976)
Br Med J
, vol.1
, pp. 503-504
-
-
Feest, T.G.1
Burge, P.S.2
Cohen, S.L.3
-
38
-
-
0029100405
-
Acute myeloma kidney
-
Winearls C.G. Acute myeloma kidney. Kidney Int 1995, 48:1347-1361.
-
(1995)
Kidney Int
, vol.48
, pp. 1347-1361
-
-
Winearls, C.G.1
-
39
-
-
0028519859
-
Pathogenesis and treatment of myeloma kidney
-
Sanders P.W. Pathogenesis and treatment of myeloma kidney. J Lab Clin Med 1994, 124:484-488.
-
(1994)
J Lab Clin Med
, vol.124
, pp. 484-488
-
-
Sanders, P.W.1
-
40
-
-
0038187798
-
Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis
-
Torregrosa J.V., Moreno A., Mas M., et al. Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis. Kidney Int Suppl 2003, 85:S88-S90.
-
(2003)
Kidney Int Suppl
, vol.85
-
-
Torregrosa, J.V.1
Moreno, A.2
Mas, M.3
-
41
-
-
49849095031
-
Narrative review: furosemide for hypercalcemia: an unproven yet common practice
-
LeGrand S.B., Leskuski D., Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med 2008, 149:259-263.
-
(2008)
Ann Intern Med
, vol.149
, pp. 259-263
-
-
LeGrand, S.B.1
Leskuski, D.2
Zama, I.3
-
42
-
-
0026655885
-
Nasal human calcitonin for tumor-induced hypercalcemia
-
Dumon J.C., Magritte A., Body J.J. Nasal human calcitonin for tumor-induced hypercalcemia. Calcif Tissue Int 1992, 51:18-19.
-
(1992)
Calcif Tissue Int
, vol.51
, pp. 18-19
-
-
Dumon, J.C.1
Magritte, A.2
Body, J.J.3
-
43
-
-
0030342522
-
Viscosity of paraproteinemic sera
-
Tichy M. Viscosity of paraproteinemic sera. Acta Medica (Hradec Kralove) 1996, 39:41-43.
-
(1996)
Acta Medica (Hradec Kralove)
, vol.39
, pp. 41-43
-
-
Tichy, M.1
-
44
-
-
77952646938
-
Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review
-
Weide R., Koppler H., Antras L., et al. Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review. J Cancer Res Ther 2010, 6:31-35.
-
(2010)
J Cancer Res Ther
, vol.6
, pp. 31-35
-
-
Weide, R.1
Koppler, H.2
Antras, L.3
-
45
-
-
21744455759
-
Zoledronic Acid and renal toxicity: data from French adverse effect reporting database
-
Munier A., Gras V., Andrejak M., et al. Zoledronic Acid and renal toxicity: data from French adverse effect reporting database. Ann Pharmacother 2005, 39:1194-1197.
-
(2005)
Ann Pharmacother
, vol.39
, pp. 1194-1197
-
-
Munier, A.1
Gras, V.2
Andrejak, M.3
-
46
-
-
33644829447
-
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party
-
Augustson B.M., Begum G., Dunn J.A., et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 2005, 23:9219-9226.
-
(2005)
J Clin Oncol
, vol.23
, pp. 9219-9226
-
-
Augustson, B.M.1
Begum, G.2
Dunn, J.A.3
|